The downgrade from Neutral to Sell by a major analyst like UBS, accompanied by a significant reduction in the price target, suggests a bearish outlook for QuidelOrtho. This is likely due to underlying concerns about the company's future performance or market conditions affecting its sector. Such a downgrade can lead to a negative perception among investors, potentially causing a short-term decline in the stock price.